Ain Holdings Inc. · TSE:9627
Ain — Q1 FY4/24 Earnings Presentation
20 slides from Ain's earnings presentation, September 2023
Slide 1: FY4/24 1Q IR Presentation
FY4/24 1Q IR PRESENTATION September 2023
Slide 2: Results Overview
Results Overview © 2023 AIN HOLDINGS INC. All Rights Reserved. 1
Slide 3: Consolidated P/L
Consolidated P/L Net sales increased 16.2% YoY and 5.1% against the plan due to the easing of restrictions on outpatient visits following the downgrade of COVID-19 to a category-5 infectious disease and the easing of mobility restrictions. Ordinary profit increased 25.6% YoY and 60.0% against the pl
Slide 4: Dispensing Pharmacy Business (Consolidated)
Dispensing Pharmacy Business (Consolidated) Net sales increased 16.4% YoY and 4.9% against the plan due to the easing of restrictions on outpatient visits following the downgrade of COVID-19 to a category-5 infectious disease and the easing of mobility restrictions. Segment profit increased 14.7% Yo
Slide 5: Cosmetic and Drug Store Business (Consolidated)
Cosmetic and Drug Store Business (Consolidated) Net sales up 21.8% YoY and 8.5% against the plan because customer numbers were firm amid a recovery in mobility for both domestic shoppers and overseas visitors. Segment profit increased 332.9% YoY and 129.0% against the plan due to increase of sales.
Slide 6: Consolidated B/S
Consolidated B/S Net cash became ¥39,576 million and shareholders’ equity ratio became 53.7%. We are maintaining a sound financial structure. End-FY4/23 (¥ million) End-FY4/24 1Q (¥ million) Assets Liabilities Assets Liabilities Current assets Current Current assets Current 98,305 92,986 101,400 97,
Slide 7: Assets
Assets The balance of total assets increased ¥3,897 million from the end of the previous fiscal year because of increase in merchandise due to a rise in inventories of COVID-19 treatments, and an increase in buildings and structures due to the new store openings. (¥ million) End-FY4/23 1Q End-FY4/23
Slide 8: Liabilities and Net Assets
Liabilities and Net Assets Accounts payable increased ¥6,161 million due to increase in pharmaceutical inventories and new store openings. Short-term and long-term debt decreased ¥1,195 million due to repayment of loans payable. (¥ million) End-FY4/23 1Q End-FY4/23 End-FY4/24 1Q Change Accounts paya
Slide 9: FY4/24 Plan (Consolidated)
FY4/24 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2024 increase 4.5% YoY and ordinary profit decrease 4.5% YoY due to our plans to open 50 dispensing pharmacies and 12 cosmetic and drug stores. FY4/22 FY4/23 FY4/24 YoY YoY （¥ million） results results plan
Slide 10: Review
Review © 2023 AIN HOLDINGS INC. All Rights Reserved. 9
Slide 11: Review (YoY)
Review (YoY) Ordinary profit increased ¥0.8 billion due to increase of net sales in dispensing pharmacy business and cosmetic and drug store business, etc. Net sales Ordinary profit ¥94.6 billion +¥13.2 billion ¥3.8 billion +¥0.8 billion ¥3.0 billion +25.6% ¥81.4 billion +16.2% ■Dispensing Pharmacy
Slide 12: Strategy
Strategy © 2023 AIN HOLDINGS INC. All Rights Reserved. 11
Slide 13: Strategy
Strategy Expansion of top-line ■Dispensing Pharmacy Plan to open 50 pharmacies（Organic 30, M&A 20） ■Cosmetic and Drug Store Plan to open 12 stores Recruiting and training of human resources ■Planning to hire 650 newly graduated pharmacists and 400 medical support staff ■Make field manager system and
Slide 14: Expansion of top-line
Expansion of top-line ■Dispensing Pharmacy Plan to open 50 pharmacies（Organic 30, M&A 20） ■Cosmetic and Drug Store Plan to open 12 stores FY4/24 1Q Results FY4/24 Plan 112 1,293 1,337 18 Dispensing Dispensing Pharmacies 1,215 Pharmacies 1,249 Cosmetics and 78 Cosmetics and 88 163 Drug stores Drug st
Slide 15: Expansion of top-line: Openings and Closures
Expansion of top-line ■Dispensing Pharmacy Plan to open 50 pharmacies（Organic 30, M&A 20） ■Cosmetic and Drug Store Plan to open 12 stores ■ Plan and Results FY4/24 1Q FY4/24 Plan Results Plan Dispensing Pharmacy 11 10 50 Organic 5 5 30 Opening M&A 6 5 20 Cosmetic and drug store 1 1 12 Total 12 11 62
Slide 16: Recruiting and training of human resources
Recruiting and training of human resources ■Planning to hire 650 newly graduated pharmacists and 400 medical support staff ■Make field manager system and medical supervisor system more established ■Training of human resources In April 2023, new 543 pharmacists has joined our group. We aim to hire, n
Slide 17: Expansion of AINZ&TULPE
Expansion of AINZ&TULPE ■Opening stores in prime locations and medium and long term store opening strategy AINZ & TULPE plan to open in FY4/24 12 stores (Tentative) COCONO SUSUKINO (Plan to open in Nov. 2023 ) Tokyo (Plan to open in Feb. 2024 ) Kanagawa COCOLIA TAMA CENTER （ Plan to open in Sep. 202
Slide 18: FY4/24 Plan (Consolidated)
FY4/24 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2024 increase 4.5% YoY and ordinary profit decrease 4.5% YoY due to our plans to open 50 dispensing pharmacies and 12 cosmetic and drug stores. FY4/22 FY4/23 FY4/24 YoY YoY （¥ million） results results plan
Slide 19: AIN HOLDINGS INC. Corporate Planning Division
Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL(81)11-814-0010 FAX(81)11-814-5550 https://www.ainj.co.jp/corporate/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This d
Slide 20: AIN GROUP
AIN GROUP